Clinical Trial Update: Efficacy and Safety Study of rhGM-CSF Gel to Treat Deep 2nd Thickness Burn [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of rhGM-CSF Gel for deep partial-thickness burns has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Partial-thickness Burn

Drugs mentioned

• rhGM-CSF Gel (recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) gel)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Deep Partial Thickness Burn | Phase 4 | Status: COMPLETED